Cargando…

Novel therapies for proliferative retinopathies

Proliferative retinopathies, such as neovascular age–related macular degeneration and proliferative diabetic retinopathy, are a special health issue due to their contribution to irreversible blindness. Although the promoting conditions and physiopathology of proliferative retinopathies are different...

Descripción completa

Detalles Bibliográficos
Autores principales:	Martinez-Alejo, Juan Manuel, Baiza-Duran, Leopoldo Martin, Quintana-Hau, Juan de Dios
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9720790/ https://www.ncbi.nlm.nih.gov/pubmed/36479142 http://dx.doi.org/10.1177/20406223221140395

Ejemplares similares

Pharmacokinetics and Safety of an Intravitreal Humanized Anti-VEGF-A Monoclonal Antibody (PRO-169), a Biosimilar Candidate to Bevacizumab
por: Muñoz-Villegas, Patricia, et al.
Publicado: (2021)

Comparing The Efficacy Of An Anti-Human VEGF-A Neutralizing Antibody Versus Bevacizumab On A Laser-Induced Choroidal Neovascularization (CNV) Rhesus Monkey Model
por: Olvera-Montaño, Oscar, et al.
Publicado: (2019)

Comparison of timolol 0.5% + brimonidine 0.2% + dorzolamide 2% versus timolol 0.5% + brimonidine 0.2% in a Mexican population with primary open-angle glaucoma or ocular hypertension
por: Baiza-Durán, Leopoldo Martín, et al.
Publicado: (2012)

Evaluation of the Rheological Properties, Preclinical Safety, and Clinical Effectiveness of a New Dispersive Ophthalmic Viscoelastic Device for Cataract Surgery
por: Palacio-Pastrana, Claudia, et al.
Publicado: (2022)

Candidate Genes for Proliferative Diabetic Retinopathy
por: Petrovič, Daniel
Publicado: (2013)

Refining vitrectomy for proliferative diabetic retinopathy
por: Chen, San-Ni, et al.
Publicado: (2023)

Levocetirizine Inhibits Migration of Immune Cells to Lymph Nodes and Induces Treg Cells in a Murine Type I Allergic Conjunctivitis Model
por: García-Zepeda, Sihomara, et al.
Publicado: (2012)

Wide-field imaging in proliferative diabetic retinopathy
por: Liu, T. Y. Alvin, et al.
Publicado: (2019)

Heritability of Proliferative Diabetic Retinopathy
por: Hietala, Kustaa, et al.
Publicado: (2008)

Proliferative diabetic retinopathy in acromegaly
por: Malhotra, Chintan
Publicado: (2010)

Effects of Intravitreal Bevacizumab Therapy in Patients with Proliferative Diabetic Retinopathy
por: Ribeiro de Carvalho, Giuliana, et al.
Publicado: (2020)

Proliferative and inflammatory factors in the vitreous of patients with proliferative diabetic retinopathy
por: Chernykh, VV, et al.
Publicado: (2015)

Surgery for Proliferative Diabetic Retinopathy: New Tips and Tricks
por: Oellers, Patrick, et al.
Publicado: (2016)

A Paradigm Shift in the Management Approaches of Proliferative Diabetic Retinopathy: Role of Anti-VEGF Therapy
por: Raman, Rajiv, et al.
Publicado: (2022)

Proliferative retinopathy and neovascularization of the anterior segment in female type 2 diabetic rats
por: Mancini, Jorge E, et al.
Publicado: (2013)

Growth Factors in Proliferative Diabetic Retinopathy
por: Khan, Zia Ali, et al.
Publicado: (2003)

Predicting Development of Proliferative Diabetic Retinopathy
por: Harris Nwanyanwu, Kristen, et al.
Publicado: (2013)

The Effects of Pleiotrophin in Proliferative Diabetic Retinopathy
por: Zhu, Xuemei, et al.
Publicado: (2015)

Efficacy and safety of chondroitin sulfate/xanthan gum versus polyethylene glycol/propylene glycol/hydroxypropyl guar in patients with dry eye
por: Llamas-Moreno, Juan Francisco, et al.
Publicado: (2013)

Update on the Management of Diabetic Retinopathy: Anti-VEGF Agents for the Prevention of Complications and Progression of Nonproliferative and Proliferative Retinopathy
por: Bahr, Tyler A., et al.
Publicado: (2023)

Neurotrophins and Neurotrophin Receptors in Proliferative Diabetic Retinopathy
por: Abu El-Asrar, Ahmed M., et al.
Publicado: (2013)

Near-infrared reflectance imaging of neovascularization in proliferative diabetic retinopathy
por: Vaz-Pereira, Sara, et al.
Publicado: (2020)

Triamcinolone and Bevacizumab as Adjunctive Therapies to Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
por: Lopez-Lopez, F., et al.
Publicado: (2012)

Systematic evaluation of combined herbal adjuvant therapy for proliferative diabetic retinopathy
por: Huai, Baogeng, et al.
Publicado: (2023)

Lymphatic Vascular Structures: A New Aspect in Proliferative Diabetic Retinopathy
por: Gucciardo, Erika, et al.
Publicado: (2018)

Homocysteine Serum Levels in Diabetic Patients with Non Proliferative, Proliferative and without Retinopathy
por: Malaguarnera, Giulia, et al.
Publicado: (2014)

Automated detection of proliferative retinopathy in clinical practice
por: Karperien, Audrey, et al.
Publicado: (2008)

Characterisation of the vitreous proteome in proliferative diabetic retinopathy
por: Wang, Hao, et al.
Publicado: (2012)

Choroidal Osteoma Accompanied by Proliferative Diabetic Retinopathy
por: Choi, Hyun Sup, et al.
Publicado: (2018)

Pupillary responses in non-proliferative diabetic retinopathy
por: Park, Jason C., et al.
Publicado: (2017)

Plasma metabolomic profiling of proliferative diabetic retinopathy
por: Zhu, Xiao-Rong, et al.
Publicado: (2019)

Hypertension: A Cause of Bilateral Proliferative Retinopathy
por: Jung, Eric E., et al.
Publicado: (2023)

Therapeutic Interventions against Inflammatory and Angiogenic Mediators in Proliferative Diabetic Retinopathy
por: Gologorsky, Daniel, et al.
Publicado: (2012)

The unmet need for better risk stratification of non‐proliferative diabetic retinopathy
por: Sivaprasad, S., et al.
Publicado: (2018)

Proteomic Analyses of Vitreous in Proliferative Diabetic Retinopathy: Prior Studies and Future Outlook
por: Weber, Sarah R., et al.
Publicado: (2021)

Long‐term outcomes of vitrectomy for proliferative diabetic retinopathy
por: Schreur, Vivian, et al.
Publicado: (2020)

The Patient Experience with Diabetic Retinopathy: Qualitative Analysis of Patients with Proliferative Diabetic Retinopathy
por: Sherman, Steven A., et al.
Publicado: (2022)

Prognostic factors for the development and progression of proliferative diabetic retinopathy in people with diabetic retinopathy
por: Perais, Jennifer, et al.
Publicado: (2023)

Novel therapies for diabetic retinopathy
por: Kupis, Magdalena, et al.
Publicado: (2022)

Oxidants, antioxidants and mitochondrial function in non-proliferative diabetic retinopathy
por: Rodríguez-Carrizalez, Adolfo Daniel, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_p0b5a74q14ldc636jkhnu3hj6h